Co-administration of Thymoquinone and Propolis in Liposomal Formulations as a Potential Approach for Treatment of Acetic Acid-Induced Ulcerative Colitis: Physiological and Histopathological Analysis

A severe form of autoimmune-mediated inflammatory bowel disease (IBD) is termed as ulcerative colitis (UC) which ultimately results in significant mucosal damage and ulceration. Herbal remedies may be employed as an alternative for treatment of UC instead of conventional medications such as Sulfasalazine. Promising natural remedies for the treatment of IBD, including colitis, are propolis extract (PP) and thymoquinone (TQ). This study is aimed at assessing the potential of liposomal formulations of TQ and Egyptian PP in combination therapy on improving their therapeutic efficacy against ulcerative colitis in order to maximize the potential of their beneficial clinical effects. Clinical, biochemical, and histological evaluations of colonic mucosal damage and inflammation were evaluated. The results exhibited a significant increase in tissue MDA, TNFα, and nitrite levels with activation of caspase-3 in the acetic acid-induced colitis group, which is predominantly downregulated in the treatment groups. The prepared formulations of TQ and PP revealed liposomal vesicles in a nanoscale size (192 ± 20.3 and 98.2 ± 20.3 nm, respectively) and accepted stability indicated with a zeta potential of 19.3 ± 0.11 and 17.1 ± 0.25 mV, respectively. They showed an entrapment efficiency of 85.3 ± 12.6% and 69.3 ± 11.8%, respectively. At comparable doses, combination therapy with thymoquinone liposomes and propolis liposomes considerably outperformed free TQ and free PP in reducing inflammation of UC as shown in the present study by clinical, biochemical, and histological evaluations.


Introduction
Inflammatory bowel disease (IBD) is a prevalent chronic inflammatory disorder of the GIT.Various etiological factors including hereditary, immunological, and ecological have been associated with its pathophysiology.Crohn's disease (CD) and ulcerative colitis (UC) are two major subdiseases of IBD.UC involves only the colon and rectum [1].Certain data suggest that IBD in humans is a one of the most common risk factors leading to colorectal cancer and potentially fatal respiratory or circulatory complications [2].
There is still much to learn about UC's pathogenic mechanisms and etiology.The pathogenesis of UC is believed to include a number of factors, including an erratic immunological response [3].Recent evidence has shown that pivotal intracellular processes, such as oxidative stress, epithelial barrier disturbance, accelerated epithelial apoptotic cell death, and suppression of immune and inflammatory cell apoptosis, are intimately connected to the immunological anomaly caused by UC and the subsequent colonic tissue damage.As a result, apoptosis is crucial for controlling intestinal epithelial homeostasis [4].
Numerous mechanisms, such as neutrophil infiltration, excessive generation of proinflammatory mediators, and increased reactive oxygen species (ROS), are thought to play a role in its pathogenesis.Tumor necrosis factor alpha (TNFα) is an essential proinflammatory mediator involved in the pathogenesis of IBD [5].TNF-α is a pleiotropic proinflammatory cytokine that is involved in a variety of cellular functions, including cell proliferation, survival, and death.Additionally, various inflammatory pathways, such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) pathways, are mediated by TNF-α signaling.The large intestine mucosa is harmed by the activation of COX-2 and inducible nitric oxide synthase (iNOS), which increases free radical production while suppressing the anti-oxidative system.In fact, the intestinal mucosa's defense mechanism is impacted by the excessive formation of ROS and nitrogen metabolites [6].
The most widely used medication for the treatment of IBD, including UC, is Sulfasalazine, which aims to reduce mucosal inflammation, complications, and disease recrudescence.Regrettably, since they require lengthy usage and can cause drug intolerance, adverse drug responses, and allergic reactions, the present medications are not much efficient.Therefore, natural remedies and medications derived from plants may be an alternative for the management of UC since, in conventional medicine, these are being given much consideration due to their few side effects, low cost, and the fact that the majority of individuals throughout the world still believe them.Several natural products, involving aloe vera, liquorice, turmeric, curcumin, Zingiber officinale, and green tea, have been reported to have an impact on UC in numerous trials [7].
Propolis is a waxy substance formed by bees through mixing exudates of plants with their saliva and beeswax [8].Propolis extract is proposed as a promising natural product for controlling IBD including colitis [9,10].Results showed that administration of Korean propolis minimized the Dextran Sulfate Sodium (DSS)-induced colitis in mice in a dose-dependent style [9].Other studies revealed the impact of oral administration of rats of either Brazilian or Chinese propolis on the prevention of DSS-induced colitis in rats [11,12].Thymoquinone, the main active constituent of Nigella sativa, is another natural component with remarkable anti-inflammatory effect in the IBD [13].A previous study has reported the role of antioxidant and anti-inflammatory activity of TQ in management of inflammation and colitis [13][14][15].
Unfortunately, the therapeutic effects of most natural components are diminished due to either poor solubility and instability, as in the case of TQ which is photosensitive [16], or the inappropriate resinous nature and difficult administration, as in propolis extract.Well-designed nanocarriers have the advantages of enhancing the physical characterization of entrapped natural extracts, increasing their stability, promoting the cellular permeation, and enhancing the therapeutic effect [17][18][19].Liposomes are lipid-based nanoarchitectures that are superior to other nanocarriers due to their biological compatibility and ability to entrap both hydrophilic and lipophilic components [20,21].The efficiency of liposomes in enhancing the stability, delivery, and targeting of entrapped cargo for the treatment of ulcerative colitis has been reported in previous studies [22][23][24][25].This study is aimed at evaluating the potential of combination therapy of liposomal formulations of TQ and Egyptian PP on enhancing their therapeutic efficiency against ulcerative colitis to maximize the potential of their favorable clinical effects.

Formulation of Thymoquinone and Propolis Liposomes
Thymoquinone-containing liposomes (Lip-TQ) were prepared adopting the reported spraying technique [26].Briefly, thymoquinone (TQ) (2.5 mg/ml), cholesterol (33.33% molar concentration), and PL 90H® (80 mmol/ml) were dissolved in 2 ml of ethanol and then moved to umber glass closed spraying device.The organic phase was sprayed on the surface of 2 ml sucrose solution (9% w/v) at 37°C with continuous stirring at 1200 rpm until complete evaporation of ethanol.
Formulated liposomes were stored at 4°C overnight to permit the stabilization of the formed bilayer [27].The liposomal formulations were then ready for further investigations.Both particle size and polydispersity index (PDI) were estimated after dilution with deionized water using a Mastersizer 3000E (Malvern Instruments, Malvern WR14 1X, UK).Average size and PDI were calculated from triplicate measurements.Scanning electron microscopy (SEM) was adopted for imaging of diluted samples with JEOL (JM 1000 EX, Peabody, MA, USA) after drying on carbon grid.

Entrapment Efficiency (EE %) of TQ and PP in Liposomes
Unentrapped TQ and PP were separated from Lip-TQ and Lip-PP, respectively, by centrifugation using cooling centrifuge (Hermle® Z326 K, Germany) at 12,000 rpm for 60 min at 4°C.Two washing cycles were maintained for Lip-TQ and Lip-PP.The supernatants were collected after each washing cycle and analyzed using Spectronic Genesys® (Winspec Software, Spectronic, USA) at 257 nm and 410 nm, respectively, to estimate the unencapsulated TQ and PP, after proper dilution, using the standard calibration curves [27,19].Percentage of encapsulated drug was determined by indirectly subtracting the free amount of the drug from the total added amount [28] using the equation [28].

Particle Size Analysis and Zeta Potential Determination
Liposomal size was measured using laser light diffraction methods (Mastersizer 3000E Malvern Instruments, UK).In a summary, pure deionized water was used to dilute the liposomal formulation before it was analyzed at 25°C.Average data were utilized after the procedures were performed three times [29].
Using Mastersizer, the charges on the liposomal surface were also evaluated using Malvern Zetasizer.Using Millipore water, the produced liposomes were diluted, and their zeta potential was assessed [30].

In Vitro Release Study
Using the semipermeable membrane that had been submerged in normal saline solution 0.9% for an hour prior to usage, the in vitro release of TQ and PP from the produced TQ-Lip and PP-Lip was investigated.The membrane was then attached to a reservoir compartment of Franz cell containing 20 ml of receptor media (pH 7.4) made of phosphate citrate buffer and 1% tween 80.To the sample compartment, aliquots of the TQ-Lip and PP-Lip formulations were added; both of which contained 1 mg of the active ingredient.In a thermostatic shaker, the system was shaken at 37 ± 0.5°C and 50 ± 10 rpm.Over the course of 24 h, each 1 ml withdrawn of the release medium was substituted with equal volume of fresh media and kept at the same temperature.Flavonoidal levels (TQ and PP concentrations) were measured spectrophotometrically at 257 and 410 nm, respectively.All experiments were carried out in triplicate.The average values from each experiment were reported, and the cumulative percentage of the released flavonoids was determined and plotted versus time.

Ethical Approval
The Animal Care Committee of the Faculty of Pharmacy, Minia University, Minia, Egypt, approved the study (ES 14/2021) and issued recommendations for the careful handling of animals that were adhered to in accordance with all applicable international standards and guarantee compliance with the European Union Directive 2010/63/ EU on animals.

Animals
Male Sprague Dawley rats that were 4-6 weeks old and weighed 150-200 g were housed in the Faculty of Medicine at Minia University's laboratory animal house.They were housed in standard lab settings with a regular day/night cycle.Standard stainless-steel cages were utilized to keep all rats.For 1 week prior to the beginning of the study, they were allowed to roam freely in their cage and were fed commercial rat chow.

Induction of Ulcerative Colitis
Induction of ulcerative colitis was maintained by the method outlined by Mousavizadeh et al. (2009), where colon tissue was experimentally ulcerated with little modification.Rats were left fasting for 24 h and then anesthetized with ether, and a gel-lubricated soft pediatric catheter (2.7 mm) was inserted 6-8 cm proximal to the anus containing 4% acetic acid (AA).To stop AA leakage after administration, rats were kept horizontally for 2 min.Animals used as controls performed the same procedure using equal volume of saline in place of the AA solution.Rats' body weights were recorded every day.

Experimental Design
Six groups of 10 rats each were divided as follows: 1. Group I (control group): rats received normal saline intrarectally with no other treatment and were kept randomly wandering in their cages for 10 days.2. Group II (AA-induced colitis group): rats received acetic acid (AA) intrarectally and were sacrificed 10 days later.

General Assessment of Colitis
The activity index of the disease (DAI), which employs a score system for evaluating weight loss, rectal bleeding, and stool consistency, was used to evaluate disease activity.The sum of all the grades was determined for each animal: body weight loss (0 indicates none;

Biochemical Analysis
Ten days after the treatment and after determining DAI, animals were deeply anesthetized then sacrificed [34], blood samples were collected from the left jugular vein at room temperature, and sera were separated by centrifugation at 3000 × g for 10 min at 4°C and then stored in aliquots at − 80°C till used.Five-to six-centimeter-long colon specimens were dissected and washed with saline solution.Samples were photographed and weighed and then divided into two parts, one for molecular and the other for histological examination.For histopathological evaluation, cross sections were fixed in 10% formaldehyde solution.Until analysis, the tissues were kept at − 80°C.

Serum Samples Used for Measuring
Collected sera were used to determine the values of white blood cells (WBCs), lymphocytes, hemoglobin, albumin, and triglycerides in control and treated groups.

Molecular Assessment of the Colon
Predetermined weight of the colon was homogenized in phosphate buffer and centrifuged at 5000 rpm for 10 min at 4°C.Supernatants were utilized for determination of malondialdehyde (MDA) as described by Ohkawa et al. [35].ELISA kit (Lab Vision Corporation, USA) was used to evaluate concentration of tumor necrosis factor-α (TNFα) according to the manufacturer's instructions.Colorimetric kit (Biodiagnostic, Egypt) was used to evaluate concentration of nitrite, an indicator of nitric oxide (NO) production.

Morphometric Analysis
Using monoclonal anti-caspase-3 antibodies, a digital image analysis assay was performed in order to evaluate the results using the light microscope (Olympus CX-31, Tokyo, Japan) (equipped with ImageJ software).Four tissue blocks for cross and longitudinal sectioning/animal were randomly selected, and serial sections (one cross and one longitudinal section per block) were selected, and three microscopic fields/sections were randomly selected.Area % of caspase-3 immunopositivity was quantified from 10 non-overlapping fields for each rat in each group.

Preparation and Characterization of Lip-TQ and Lip-PP
Liposomal formulations of thymoquinone (TQ) and propolis (PP) imaged by SEM were successfully formulated as spherical vesicles with homogenous size distribution (Fig. 1).LIP-TQ exhibited particle size of 192 ± 20.

In Vitro Release Study
As shown in Fig. 2, the release of TQ from its free solution and LIP-TQ vesicles was found to be 85.3 ± 12.6 and 29.5% at 6-h timepoint, respectively.Also, the release of PP from its free extract and Lip-PP vesicles was found to be 89.2 and 45.1% at 6-h timepoint, respectively.After 24 h, Lip-TQ release reached 65.2% while Lip-PP release was 45.1%.

Assessment of Colitis
To investigate the severity of colitis, its clinical signs including body weight loss, diarrhea, and rectal bleeding were explored.Rats challenged with acetic acid (AA) in group II displayed with high DAI scores associated with incidence of diarrhea and rectal bleeding, a reliable marker of colon inflammation.Sulfasalazine in group III alleviated these changes and diminished the severity of colonic injury as compared to group II.Moreover, TQ and PP combination in group IV showed significant lower DAI scores as compared to group II and also group III treated by Sulfasalazine.Interestingly, LIP-TQ and LIP-PP-treated group (group V) ameliorates the severity of AA-induced injury in rats and showed the lowest DAI scores compared with all treated groups.On the other hand, rats that received lipid vesicle after induction of colitis showed insignificant effect on DAI scores as compared to AA-induced colitis rats in group II and significantly the highest as compared to all other treated groups (Fig. 3).

Biochemical and Hematologic Parameters of Treated Groups
The elevated white blood cell and lymphocytes with reduced hemoglobin, albumin, and triglyceride values revealed that AA rectal treatment could induce severe inflammation in the mouse colon (Table I).Interestingly, oral administration of combination of PP (25 mg/kg) and TQ (5 mg/kg) significantly reduced the number of WBCs compared to the AA-treated group (P < 0.001); further reduction in WBCs was obtained upon treatment with combination of LIP-TQ and LIP-PP (group V) compared to groups of animals treated with Sulfasalazine (group III) and combination of TQ and PP (group IV) (P < 0.001 and P < 0.01, respectively).Count of lymphocytes was also reduced significantly due to treatment with combination of TQ and PP.Simultaneously, administration of LIP-TQ and LIP-PP (group V) has significantly reduced lymphocyte count compared to treatment with Sulfasalazine or combination of PP and TQ, respectively (P < 0.01).In addition, the combined treatment of LIP-TQ and LIP-PP had significantly elevated hemoglobin and albumin levels compared to combined treatment with PP and TQ and treatment with Sulfasalazine (P < 0.05 and P < 0.001, respectively).However, both the combined treatment of PP and TQ and the combined treatment of their liposomal dosage forms caused comparable enhancement in the triglyceride level.

Assessment of the Colon Parameters
The data of the present study in Table II clearly demonstrated that the tissue MDA, TNFα, and nitrite levels were significantly higher in the acetic acid-induced colitis (group II) and in rats that received lipid vesicle (group VI) compared with all other treated groups.On the other hand, these parameters were significantly lower in all treated groups (III, IV, V), but rats in group V treated by combination of LIP-TQ and LIP-PP showed the lowest mean value among all the experimental treated groups followed by group IV than III.

H&E Sections
The group showed normal histological structure of the colon.The mucosa was folded intact and continuous, with regular arranged tubular crypts, covered with simple columnar epithelium.The crypts are arranged perpendicular to the muscularis mucosae, and their bases contact the upper edge of the muscularis mucosae (Fig. 4

con).
Group II showed distorted mucosa that appeared with absent folding, lost columnar epithelial lining and goblet cells, and malformed and disorganized crypts.Heavy inflammatory cell infiltration associated with congested and dilated blood vessels and edema together with areas of extravasated blood was observed in the mucosa and in the widened submucosa (Fig. 4a).The most numerous inflammatory cells Fig. 3 The disease activity index (DAI) in the different experimental groups.Data are expressed as mean ± S.E.M. of 10 rats in each group.a  observed were eosinophils, mast cells, and neutrophils (Fig. 4b, c).Activity is defined as the presence of neutrophil infiltration of surface epithelium, crypt epithelium, and/or collecting within crypt lumens (focal crypt abscesses), less commonly superficial mucosal erosions.Rarely basal lymphocytosis between the bottom of the crypts and the upper edge of the muscularis mucosae was noticed (Fig. 4d).
In group III, patchy inflammation was noticed; mononuclear inflammatory cells were present in the lamina propria but not noticeably expand it (Fig. 4e).In group IV, healing was characterized by absence of active inflammatory cells and appearance of cells in resolution of inflammation and regeneration which are macrophages (Fig. 4f).The structural changes, e.g., atrophy, irregularity, shortening of the crypts, and thickening of the muscularis mucosae, were rarely observed (Fig. 4g).In group V, there may no longer be crypt injury (including erosion or ulceration); instead, the crypts showed signs of mitotic activity including varying degrees of nuclear enlargement and stratification (Fig. 4h).The lamina propria showed increased phagocytic cells (Fig. 4i).Morphologic picture of group VI resembled that of the control group (Fig. 4j).

Immune-Histochemical Changes of Caspase III
The control group I showed scarce brown cytoplasmic immune reaction (Fig. 5a).Group II showed widespread cytoplasmic and unclear immuno-reaction in the epithelial cells and mucosal and submucosal C.T cells (Fig. 5b).In addition, the recovered groups healed from UC groups III and IV showed a decrease in caspase-3 immuno-positivity when compared with the UC group (Fig. 5c, d).The reaction was the weakest in group V treated with thymoquinone and propolis carried on nanoparticles (Fig. 5e).Group VI showed widespread cytoplasmic and unclear immuno-reaction in the epithelial cells and C.T cells similar to that of the control group (Fig. 5f).

Morphometric Results Using the Light Microscope
Regarding caspase-3 immunopositivity, as shown in Table III, the area % for caspase-3 immuno-positivity was significantly increased in group II if compared to that of the control and treated groups.In addition, the healing from UC in treated groups III and IV resulted in a decrease in % area for caspase-3 immuno-expression if compared with the UC group.The result was significant in group V treated with combination of LIP-TQ.Group VI showed an increase in area % for caspase-3 immuno-expression more or less similar to that of the UC group II.

Discussion
Despite having numerous advantageous therapeutic features, the clinical application of TQ and PP has been severely limited because of its hydrophobic nature, photosensitivity, temperature, and pH instability.Liposomes have long been regarded as an excellent drug delivery system because they may effectively be loaded with the lipophilic drugs that would otherwise have limited absorption and bioavailability.The lipophilic medications such as TQ and PP can be considered very effective when utilized as a liposomal formulation.This study revealed.
According to the results of the in vitro release profile, the inclusion of TQ and PP in liposomal formulation significantly slows down the release of the encapsulated drugs in comparison to the burst release of the free drug.These findings point to a drug's sustained release impact as a result of its inclusion into liposomal formulations, which will be a controlled strategy for dealing with any side effects following clinical use.Moreover, the small molecular size of the prepared liposomes guarantees the enhanced cellular uptake of the entrapped cargo [38,39] affording enhanced therapeutic effect compared to the free unencapsulated combination.This is apparent in the enhancement of biochemical, hematologic, histological, and different colon parameters in animals receiving the liposomal formulations of TQ and propolis compared to those receiving the free drugs.Ulcerative colitis, induced by experimental technique, in various animal models has gained popularity in research to investigate the pathological pathway of the disease in addition to the study of novel drugs for their promising role in the management of UC owing to the increased similarity between experimentally induced UC in animals by acetic acid and UC in patients [40].It is typically accompanied by a strong influx of neutrophils and macrophages to the site of damage, as well as superficial ulceration, inflammation, and increased vasopermeability [41].This could result in the production of hydroxyl radicals and peroxides, which substantially enhances the progression of tissue necrosis and mucosal dysfunction [42].
The administration of AA in the current study led to significantly reduced body weight, which might be related to malabsorption or reduced food intake, as well as extensive fluid loss via rectal bleeding and diarrhea.Additionally, it has been previously shown that elevated levels of cytokines, such as TNF-α, as observed in the current study, Fig. 4 Photomicrographic plate I showing distal colon; group I "con" showing the normal colon, the crypts are uniformly spaced, arranged perpendicular to the muscularis mucosae.Group II (UC) "a-c," "a" showing disorganized crypts, areas of extravasated blood "asterisks" in the mucosa "M" and in the widened submucosa "SM." "b, c" The most numerous inflammatory cells seen are eosinophils "thin black arrows," neutrophils "thin yellow arrows," and mast cells "thick arrows" that appear beside a blood vessel "BV." "d" showing superficial mucosal erosions "red arrow" and basal lymphocytosis "rectangles."Group III "e" showing patchy inflammation (tailed arrows).Group IV "f" showing numerous macrophages (arrows).Group V "g-i"; "g" showing irregular and short crypts and "h" showing nuclear enlargement (black arrows), "i" showing numerous macrophages "yellow arrows."Group VI "j" showing morphologic picture similar to the control group (H&E stain × 100 and 400) significantly contribute to body weight loss through releasing of appetite-suppressing neuropeptides in colitis [43].The DAI score could be used to determine the severity of the AA-induced colitis.The observed results revealed an elevated DAI score.The existence of at least partial surface maturation, which means that the nuclear changes in the regenerative crypts do not extend to the surface mucosa, is an indicator of regenerative changes.
In the current investigation, AA-induced colitis rats showed an elevated oxidative stress, which was proven by elevated MDA levels.According to [7], oxidative stress and inhibited antioxidant defense systems that control the production of reactive oxygen species (ROS) are one of the major causes of inflammatory illnesses.IBD in humans is largely a pathology of reactive NO radicals.Numerous studies have suggested that excessive NO, as seen in the current study by elevated levels of nitrites, may make the pathological characteristics of UC worse through mechanisms like direct damage to gut epithelial cells, neutrophil activation, and vasodilation.Additionally, NO has the ability to react with superoxide to create the extremely harmful peroxynitrite radical, which reversibly upregulates the expression of iNOS by activating NF-κB and results in a chain of harmful events [44].
Tissue sections of the distal colon of UC group II were associated with superficial ulceration and inflammatory cell infiltration including mainly eosinophils and mast cells, together with neutrophils and macrophages in the mucosa  and submucosa.This was in the same line of Kandhare et al. [41] who stated that UC was associated with enhanced vasopermeability as well as severe influx of neutrophils and macrophages.This could be explained that histiocytic "macrophages" respond to extravasated mucin or fecal material, as a result of crypt injury or surface erosion [45].Ismail and Aboulkhair [46] reported that in acute UC there was a significant decrease in the number of goblet cells but a significant increase in the number of mast cells, area % of collagen fibers, and COX-2 immuno-expression.The significant increase in area % for caspase-3 immunoexpression seen in tissue sections of UC group "II" in this study indicated enhanced apoptosis in both epithelial and connective tissue cells of the diseased colon.This was in accordance with [47] who reported that analysis of biopsies from ulcerative colitis patients demonstrated that diseaseassociated tight junction protein occluding regulates apoptosis by enhancing caspase-3 transcription.Yang et al. [48] reported increases in the levels of apoptosis-related proteins, such as caspase-3 in inflammatory bowel diseases.

Conclusion
The results of the current investigation, which demonstrated that combination therapy of Lip-TQ and Lip-PP had a stronger anti-inflammatory impact in the AA-induced colitis rats, also corroborate the greater efficacy of the combination therapy of Lip-TQ and Lip-PP when compared to the combination therapy with free TQ and free PP.
drug added − free unencapsulated drug Total drug added × 100

Fig. 1 Fig. 2
Fig. 1 SEM image and size distribution of both a TQ liposomes and b propolis liposomes

Fig. 5
Fig. 5 Photo-micrographic plate II showing distal colon.a The control group I showed scarce brown cytoplasmic immune-reaction.b Group II showed widespread cytoplasmic and nuclear immuno-reaction.c, d Treated groups III and IV showed a decrease in caspase-3

Table II
Different Colon Parameters on Acetic Acid-Induced Colitis with or Without Treatment Data are expressed as mean ± S.E.M. of 10 rats in each group MDA malondialdehyde, TNF-α tumor necrosis factor alpha, group I control group, group II AA (acetic acid)-induced colitis group, group III Sulfasalazine-treated group, group IV TQ and PP-treated group, group V LIP-TQ and LIP-PP-treated group, group VI empty LIP-treated group, TQ thymoquinone, PP propolis, LIP liposomes a Significant from control group I

Table III
Mean Area % of Caspase-3 Immuno-Expression Data are expressed as mean ± S.E.M. of 10 rats in each group Group I control group, group II AA (acetic acid)-induced colitis group, group III Sulfasalazine-treated group, group IV TQ and PP-treated group, group V LIP-TQ and LIP-PP-treated group, group VI empty LIP-treated group, TQ thymoquinone, PP propolis, LIP liposomes a Significant from control group I Significant from group IV, P ≤ 0.05 b Significant from group II c Significant from group III d